ALX Oncology Holdings Inc. (ALXO) Tops Q2 EPS by 4c

ALX Oncology Holdings Inc. (NASDAQ: ALXO) reported Q2 EPS of ($0.84), $0.04 better than the analyst estimate of ($0.88).

For earnings history and earnings-related data on ALX Oncology Holdings Inc. (ALXO) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• SanDisk upgraded at JPMorgan after investor day; shares climb
• JD.com (JD) Reiterated at Buy by Benchmark Amid Earnings Recovery